The House today passed legislation that would suspend through 2022 tariffs on certain infant formula base powders used to make infant formula in the United States. Congress in July passed legislation (H.R.8351) suspending tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage  to help health care providers and families locate formula.
 

Related News Articles

Headline
The Workgroup for Electronic Data Interchange advisory group yesterday urged Health and Human Services Secretary Xavier Becerra to work closely with standards…
Perspective
After Election Day, lawmakers will return to Washington to consider many important issues, including funding the government, the annual must-pass defense bill…
Headline
At an AHA virtual policy briefing today for congressional staff, hospital and health system leaders urged Congress to prioritize actions to address the…
Headline
As Congress begins to focus on its year-end agenda, AHA today urged lawmakers to prioritize certain actions to help hospitals and health systems address rising…
Headline
The House today voted 230-201 to pass a continuing resolution extending current federal funding levels for health care and other programs through Dec. 16. The…
Headline
The Senate today voted 72-25 to pass and send to the House a continuing resolution that would extend current federal funding levels for health care and…